S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
NASDAQ:QDEL

QuidelOrtho (QDEL) Stock Price, News & Analysis

$44.33
-1.20 (-2.64%)
(As of 03/4/2024 ET)
Today's Range
$43.91
$44.83
50-Day Range
$41.76
$75.44
52-Week Range
$41.75
$98.67
Volume
760,185 shs
Average Volume
1.73 million shs
Market Capitalization
$2.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.60

QuidelOrtho MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
39.0% Upside
$61.60 Price Target
Short Interest
Bearish
6.60% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.61
Upright™ Environmental Score
News Sentiment
0.49mentions of QuidelOrtho in the last 14 days
Based on 11 Articles This Week
Insider Trading
Acquiring Shares
$99,652 Bought Last Quarter
Proj. Earnings Growth
61.87%
From $2.57 to $4.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.84 out of 5 stars

Medical Sector

40th out of 960 stocks

Diagnostic Substances Industry

1st out of 13 stocks


QDEL stock logo

About QuidelOrtho Stock (NASDAQ:QDEL)

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

QDEL Stock Price History

QDEL Stock News Headlines

Analyst Scoreboard: 6 Ratings For QuidelOrtho
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
QuidelOrtho pops 6% after board fires CEO
QuidelOrtho 'vulnerable to an approach,' says Gordon Haskett
QuidelOrtho lets go off CEO Douglas Bryant
QuidelOrtho Announces Changes in Executive Leadership
QuidelOrtho Announces Changes in Executive Leadership
QuidelOrtho Corporation (QL1A.F)
QDEL Feb 2024 50.000 call
See More Headlines
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
3/04/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
7,100
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$61.60
High Stock Price Target
$81.00
Low Stock Price Target
$37.00
Potential Upside/Downside
+50.0%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
7 Analysts

Profitability

Net Income
$-10,100,000.00
Pretax Margin
-0.97%

Debt

Sales & Book Value

Annual Sales
$3.00 billion
Cash Flow
$10.71 per share
Book Value
$74.92 per share

Miscellaneous

Free Float
65,378,000
Market Cap
$2.96 billion
Optionable
Optionable
Beta
0.11

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Robert J. Bujarski J.D. (Age 55)
    Interim President, Executive VP & COO
    Comp: $2.62M
  • Mr. Joseph M. Busky CPA (Age 56)
    Chief Financial Officer
    Comp: $1.47M
  • Ms. Michelle A. Hodges (Age 63)
    Senior VP, General Counsel & Secretary
    Comp: $1.8M
  • Dr. Werner Kroll Ph.D. (Age 67)
    Senior Vice President of Research & Development
    Comp: $1.25M
  • Mr. Michael S. Iskra (Age 54)
    Interim CEO, Executive VP & Chief Commercial Officer
  • Ms. Louise M. Brandy
    Chief Information Officer
  • Mr. Patrick E. Klein
    Chief Administrative Officer
  • Ruben Argueta
    Director of Investor Relations
  • Mr. William J. FerenczyMr. William J. Ferenczy (Age 68)
    Point of Care Business Unit Leader
  • Ms. Tamara A. Ranalli (Age 51)
    Molecular Diagnostics Business Unit Leader














QDEL Stock Analysis - Frequently Asked Questions

Should I buy or sell QuidelOrtho stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" QDEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares.
View QDEL analyst ratings
or view top-rated stocks.

What is QuidelOrtho's stock price target for 2024?

7 equities research analysts have issued 12-month target prices for QuidelOrtho's stock. Their QDEL share price targets range from $37.00 to $81.00. On average, they predict the company's share price to reach $61.60 in the next twelve months. This suggests a possible upside of 39.0% from the stock's current price.
View analysts price targets for QDEL
or view top-rated stocks among Wall Street analysts.

How have QDEL shares performed in 2024?

QuidelOrtho's stock was trading at $73.70 at the beginning of the year. Since then, QDEL stock has decreased by 39.9% and is now trading at $44.33.
View the best growth stocks for 2024 here
.

When is QuidelOrtho's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our QDEL earnings forecast
.

How were QuidelOrtho's earnings last quarter?

QuidelOrtho Co. (NASDAQ:QDEL) posted its quarterly earnings data on Tuesday, February, 13th. The company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $2.01 by $0.84. The firm earned $742.60 million during the quarter, compared to analysts' expectations of $796.91 million. QuidelOrtho had a negative net margin of 0.34% and a positive trailing twelve-month return on equity of 5.54%. The company's quarterly revenue was down 14.3% compared to the same quarter last year. During the same period last year, the firm earned $1.74 EPS.

What guidance has QuidelOrtho issued on next quarter's earnings?

QuidelOrtho updated its FY 2024 earnings guidance on Tuesday, February, 13th. The company provided earnings per share guidance of 2.400-3.070 for the period, compared to the consensus earnings per share estimate of 5.070. The company issued revenue guidance of $2.8 billion-$3.1 billion, compared to the consensus revenue estimate of $3.0 billion.

What is Doug Bryant's approval rating as QuidelOrtho's CEO?

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

What other stocks do shareholders of QuidelOrtho own?

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

Who are QuidelOrtho's major shareholders?

QuidelOrtho's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.25%), Senvest Management LLC (4.49%), Burgundy Asset Management Ltd. (1.74%), Rubric Capital Management LP (1.47%), LGT Capital Partners LTD. (1.43%) and Dimensional Fund Advisors LP (1.36%). Insiders that own company stock include Charles P Slacik, Joseph M Busky, Mary Lake Ph D Polan, William J Ferenczy and William J Ferenczy.
View institutional ownership trends
.

How do I buy shares of QuidelOrtho?

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QDEL) was last updated on 3/5/2024 by MarketBeat.com Staff